Ronald Janish - Perrigo Company President

<div class='logoBackup' style='background:#0D8ECF;color: white;font-size:3em;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  President
Mr. Ronald Janish is Executive Vice President Global Operations and Supply Chain of the CompanyHe served as Senior Vice President of International and Rx Operations from 2012 until 2015 and as Managing Director of Perrigos Australian operations from 2010 to 2012. Previously, he held Senior Vice President roles for Perrigo in International Market Development, China Business Development and Global Procurement.
Age: 52  President Since 2015      
353 1 709 4000  http://www.perrigo.com
Janish was named Executive Vice President of Global Operations and Supply Chain in October 2015. He served as Senior Vice President of International and Rx Operations from 2012 until 2015 and as Managing Director of Perrigo?s Australian operations from 2010 to 2012. Previously, he held Senior Vice President roles for Perrigo in International Market Development, China Business Development and Global Procurement.

Ronald Janish Latest Insider Activity

Ronald Janish over two months ago via Macroaxis 
Perrigo Company exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

George YancopoulosRegeneron Pharmaceuticals
2016
Roman TrawickiZoetis
2015
J RamachandranDr Reddys Laboratories Ltd
2016
Glenn DavidZoetis
2016
Sripada ChandrasekharDr Reddys Laboratories Ltd
2013
Alok SonigDr Reddys Laboratories Ltd
2015
John GrayVertex Pharmaceuticals Incorpor
2019
Marion McCourtRegeneron Pharmaceuticals
2018
Alejandro BernalZoetis
2015
Cartikeya ReddyDr Reddys Laboratories Ltd
2016
Jay MarkowitzRegeneron Pharmaceuticals
2017
Ganadhish KamatDr Reddys Laboratories Ltd
2016
Christopher FenimoreRegeneron Pharmaceuticals
2017
Saumen ChakrabortyDr Reddys Laboratories Ltd
2018
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Roxanne LaganoZoetis
2015
Joyce LeeZoetis
2012
Peter PowchikRegeneron Pharmaceuticals
2006
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Heidi ChenZoetis
2012

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals